Characterization of the culture filtrate-specific cytotoxic T lymphocyte response induced by bacillus Calmette-Guerin vaccination in H-2b mice

International Immunology

Volumn 11, Issue 2, 1999, Pages 209-216

  Denis, Olivier ^a   Huygen, Kris ^a  

^a PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

Author keywords

Culture filtrate antigens; Cytotoxic T lymphocytes; Mycobacterium bovis bacillus Calmette Guerin; Tuberculosis

Indexed keywords

BCG VACCINE; BREFELDIN A; CARRIER PROTEIN; CHLOROQUINE; GAMMA INTERFERON; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DEGRANULATION; FEMALE; FILTRATION; INTRAVENOUS DRUG ADMINISTRATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CHLOROQUINE; CULTURE MEDIA; H-2 ANTIGENS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033047634     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.2.209     Document Type: Article

References (37)

1. Bloom, B. R. 1992. Tuberculosis: commentary on a reemergent killer. Science 257:1055.
2. Roche, P. W., Triccas, J. A. and Winter, N. 1995. BCG vaccination against tuberculosis: past disappointments and future hopes. Trends Microbiol. 3:397.
3. + cells. Infect. Immun. 55:2037.
4. Flynn, J. L., Goldstein, M. M., Triebold, K. J., Koller, B. and Bloom, B. R. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl Acad. Sci. USA 89:12013.
5. Modlin R. L., Melancon-Kaplan, J., Young, S. M., Pirmez, C., Kino, H., Convit, J., Rea, T. H. and Bloom, B. R. 1988. Learning from lesions: patterns of tissue inflammation in leprosy. Proc. Natl Acad. Sci. USA 85:1213.
6. Rossi., G. A., Balbi, B. and Manca, F. 1987. Tuberculous pleural effusions. Evidence for selective presence of PPD-specific T-lymphocytes at site of inflamation in the early phase of infection. Am. Rev. Respir. Dis. 136:575.
7. + T cell lines. Eur J. Immunol. 18:59.
8. + T cells in vitro. Immunology 87:339.
9. Billiau, A. 1996. Interferon-γ. biology and role in pathogenesis. Adv. Immunol. 62:61.
10. Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G. and Orme, I. C. M. 1993. Disseminated tuberculosis in interferon-γ gene-disrupted mice. J. Exp. Med. 178:2243.
11. Denis, O., Lozes, E. and Huygen, K. 1997. Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guérin-infected mice. Infect. Immun. 65:676.
12. Andersen, P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:2536.
13. York, I. A. and Rock, K. L. 1996. Antigen processing and presentation by the MHC class I major histocompatibility complex. Annu. Rev. Immunol. 14:369.
14. Germain, R. N. and Margulies, D. H. 1993. The biochemistry and cell biology of antigen-processing and presentation. Annu Rev. Immunol. 11:403.
15. Jondal, M., Schirmbeck, R. and Reimann, J. 1996. MHC class I restricted CTL responses to exogenous antigens. Immunity 5:295.
16. Rock, K. L. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 17:131.
17. Ljunggren, H. G. and Karre, K. 1985. Host resistance directed selectively against H-2-deficient lymphoma variants: analysis of the mechanism. J. Exp. Med. 142:1745.
18. Ljunggren, H. G., Stam, N. J., Öhlén, C., Neefjes J. J., Höglund, P., Eemels M., Bastin J., Schumacher, T. N. M., Townsend, A., Kärre, K. and Ploegh, H. L. 1990. Empty MHC class I molecules come out in the cold. Nature 346:476.
19. De Bruyn, J., Huygen, K., Bosmans, R., Fauville, M., Lippens, R., Van Vooren, J. P., Falmagne, P., Wiker, H. G., Harboe, M. and Turner, M. 1987. Purification, characterization and identification of a 32 kDa protein antigen of Mycobacyterium bovis BCG. Microb. Pathog. 2:351.
20. Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Feigner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Fiedman, A., Hawe, L. A., Leander, K. R., Martinez, D., Perry, H. C., Shiver, J. W., Montgomery, D. L. and Liu, M. A. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein Science 259:1745.
21. Huygen, K., Abramowicz, D., Vandenbussche, P., Jacobs, F., De Bruyn, J., Kentos, A., Drowart, A., Van Vooren, J. P. and Goldman, M. 1992. Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice. Infect. Immun. 60:2880.
22. Käbi, D., Lederman, B., Bürki, K., Zinkernagel, R. M. and Hengarder, H., 1996. Molecular mechanisms of lymphocytes-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:207.
23. Glass, A., Walsh, C. M., Lynch, D. H. and Clark, W. R. 1996 Regulation of the Fas lytic pathway in cloned CTL. J. Immunol. 156:3638.
24. Yewdell, J. W. and Bennink, J. R. 1989. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Science 244:1072.
25. 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J. Immunol. 156:4182.
26. + T cells in vitro. Eur. J. Immunol. 25:1274.
27. Ziegler, H. K. and Unanue, E. R. 1982. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc. Natl Acad. Sci. USA 79:175.
28. Molloy, A., Laochumroonvorapong, P. and Kaplan, G., 1994. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular Bacillus Calmette-Guérin. J. Exp. Med. 180:1499.
29. Laochumroonvorapong, P., Wang, J., Liu, C., Ye, W., Moreita, A. L., Elkon, K. B., Freedman, V. H. and Kaplan, G. 1997. Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect. Immun. 65:127.
30. Cooper, A. M., D'Souza, C., Franck, A. A. and Orme, I. C. M. 1997. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin-or granzyme-mediated cytolytic mechanisms. Infect. Immun. 65:1317.
31. Harding, C. V. and Song, R. 1994. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153:4925.
32. Schirmbeck, R., Melber, K. and Reimann, J. 1995. Hepatitis B virus small antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur. J. Immunol. 25:1063.
33. Mezzaccarro, R. J., Gedde, M., Jensen, E. R., Van Santen, H. M., Ploegh, H. L., Rock, K. L. and Bloom, B. R. 1996. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc. Natl Acad. Sci. USA 93:11786.
34. Tascon, R. E., Colston, M. J., Ragno, S., Stavropoulos, E., Gregory, D. and Lowrie, D. B. 1996. Vaccination against tuberculosis by DNA injection. Nature Med. 2:888.
35. Huygen, K., Content, J., Denis, O., Montgomery, D. L., Yawman, A. M., Randall Deck, R., Dewitt, C. M., Orme I. C. M., Baldwin, S., D'Souza, C., Drowart, A., Lozes, E., Vandenbussche, P., Van Vooren, J. P., Liu, M. A. and Ulmer, J. B. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Med. 2:893.
36. Zhu, X., Venkataprasad, N., Thangaraj, H. S., Hill., M., Singh, M., Ivanyi, J. and Vordermeier H. M. 1997. Function and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J. Immunol. 158:5921.
37. Zügel, U. and Kaufmann, S. H. E. 1997. Activation of CD8 T cells with specificity for mycobacterial heat shock protein 60 in Mycobacterium bovis Bacillus Calmette-Guérin-vaccinated mice. Infect. Immun. 65:3947.